ARS Pharmaceuticals, Inc. (SPRY)
5.89
-0.14
(-2.32%)
USD |
NASDAQ |
Aug 28, 16:00
5.89
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Price to Book Value : 46.81 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 46.81 |
| August 27, 2026 | 47.92 |
| August 26, 2026 | 47.92 |
| August 25, 2026 | 45.46 |
| August 24, 2026 | 42.52 |
| August 21, 2026 | 43.75 |
| August 20, 2026 | 43.75 |
| August 19, 2026 | 50.70 |
| August 18, 2026 | 50.07 |
| August 17, 2026 | 49.59 |
| August 14, 2026 | 44.90 |
| August 13, 2026 | 48.48 |
| August 12, 2026 | 48.08 |
| August 11, 2026 | 47.29 |
| August 10, 2026 | 46.97 |
| August 07, 2026 | 48.95 |
| August 06, 2026 | 44.11 |
| August 05, 2026 | 42.60 |
| August 04, 2026 | 42.28 |
| August 03, 2026 | 43.39 |
| July 31, 2026 | 40.77 |
| July 30, 2026 | 44.74 |
| July 29, 2026 | 46.33 |
| July 28, 2026 | 45.06 |
| July 27, 2026 | 45.78 |
| Date | Value |
|---|---|
| July 24, 2026 | 47.21 |
| July 23, 2026 | 47.68 |
| July 22, 2026 | 48.16 |
| July 21, 2026 | 50.54 |
| July 20, 2026 | 51.18 |
| July 17, 2026 | 55.63 |
| July 16, 2026 | 59.29 |
| July 15, 2026 | 60.00 |
| July 14, 2026 | 60.48 |
| July 13, 2026 | 61.51 |
| July 10, 2026 | 63.10 |
| July 09, 2026 | 62.62 |
| July 08, 2026 | 64.37 |
| July 07, 2026 | 65.09 |
| July 06, 2026 | 66.20 |
| July 02, 2026 | 68.03 |
| July 01, 2026 | 63.10 |
| June 30, 2026 | 63.66 |
| June 29, 2026 | 13.86 |
| June 26, 2026 | 13.83 |
| June 25, 2026 | 12.99 |
| June 24, 2026 | 17.07 |
| June 23, 2026 | 16.65 |
| June 22, 2026 | 16.16 |
| June 18, 2026 | 15.63 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Passage Bio, Inc. | 3.264 |
| Vertex Pharmaceuticals, Inc. | 6.778 |
| Capricor Therapeutics, Inc. | 2.263 |
| Kyntra Bio, Inc. | -- |
| Zentalis Pharmaceuticals, Inc. | 1.896 |
Price to Book Value Related Metrics
| PS Ratio | 4.993 |
| PEG Ratio | -0.0079 |
| Price | 5.89 |
| Earnings Yield | -36.89% |
| Market Cap | 585.69M |
| PEGY Ratio | -0.0079 |